Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019204 (
hepatocellular carcinoma
)
71,386
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Using chromatography on diethylaminoethyl (DEAE) cellulose, we measured biliary alkaline phosphatase (BALP; EC 3.1.3.1) activities in sera from 182 patients, most with hepatobiliary disorders but some with non-hepatobiliary diseases. Relative BALP activities were extremely low in otherwise healthy carriers of hepatitis B virus (mean: 5.4 U/L) and in patients with non-hepatobiliary diseases (mean: 5.3 U/L). Although BALP activities were detectable in some cases of liver cirrhosis and chronic hepatitis, these values were generally low (respective means: 12.6 and 12.0 U/L). High BALP activities were detected in patients with primary
hepatocellular carcinoma
, secondary metastatic liver tumors, and
obstructive jaundice
: mean values were 27.2, 37.2, and 73.6 U/L, respectively. There was no correlation between BALP activity and bilirubin concentration in patients with
obstructive jaundice
, nor between BALP activities in
obstructive jaundice
caused by stones and in those caused by extrahepatic tumor. Some patients with primary
hepatocellular carcinoma
had high BALP but low alpha-fetoprotein (AFP) values, some others the reverse. Based on AFP alone, the sensitivity for detecting
hepatocellular carcinoma
was 79%; adding BALP in parallel improved the sensitivity to 97%. We found minicolumn chromatography on DEAE-cellulose useful for determining BALP activity in hepatobiliary diseases.
...
PMID:Biliary alkaline phosphatase measured by mini-column chromatography on DEAE-cellulose: application to detection of hepatobiliary diseases. 247 88
The authors measured alkaline phosphatase isozyme I (ALP-I) in sera of 24 brain-damaged patients and four with disorders other than brain damage. The study population comprised three patients with postresuscitation encephalopathy, four with ruptured cerebral aneurysms, 14 with acute subdural hematoma and cerebral contusion, and three with nontraumatic intracerebral hemorrhage. ALP-I detected in brain damage is physicochemically different from the other known ALP-Is that appear in patients with
obstructive jaundice
or
hepatoma
. In the brain-damaged patients, ALP-I became elevated about 7 days after admission and markedly increased as secondary brain damage developed. Excluding patients who died within 9 days of admission, the maximum serum ALP-I concentration was well correlated with the functional outcome. In cases in which barbiturate therapy was effective, the appearance of ALP-I was delayed and its elevation was suppressed. The results of this study suggest that measurement of serum ALP-I is useful not only in the management but also in predicting the prognosis of brain damage.
...
PMID:Measurement of serum alkaline phosphatase isozyme I in brain-damaged patients. 248 67
A rare autopsy case of small
hepatocellular carcinoma
presenting as an intrabiliary pedunculated mass is reported. The patient, 60-year-old man, presented with
obstructive jaundice
and died 1 month later. At autopsy, an intrabiliary pedunculated tumor measuring 3.5 x 2.0 x 2.0 cm was found in the hepatic, right hepatic, and right posterior segmental bile ducts. The intraductal tumor was attached to the segmental bile ductal wall, where a tumor measuring 2.0 x 0.9 cm was found in the parenchyma. The parenchymal tumor was continuous with the intrabiliary mass. Histologically, the tumor was a
hepatocellular carcinoma
showing acidophilic granular cytoplasm with occasional hyaline globules and was structurally arranged in a vague trabecular pattern. Immunohistochemically, tumor cells were positive for alpha-fetoprotein and alpha 1-antitrypsin, but was negative for keratin. We present a brief review of the literature of such icteric hepatocellular carcinomas.
...
PMID:Small hepatocellular carcinoma presenting as intrabiliary pedunculated polyp and obstructive jaundice. 255 56
A prospective study was carried out at Kenyatta National Hospital (KNH) between June 1987 and September 1988 to look at some aspects of
obstructive jaundice
in patients above 12 years of age. Screening for cases was done by use of abdominal ultrasonography. A total of 20 cases (11 females, 9 males) were diagnosed. Carcinoma of the head of pancreas accounted for 55% of cases of the obstruction, followed by gallstones (10%),
hepatocellular carcinoma
(10%) and gall bladder tumour (10%).
...
PMID:Some aspects of obstructive jaundice at Kenyatta National Hospital. 269 Dec 32
We treated a patient with
hepatocellular carcinoma
in whom jaundice was caused by obstruction of the common hepatic duct because of compression by the tumor. Percutaneous transhepatic cholangiodrainage was performed preoperatively. The tumor was entirely in the medial segment of the liver, without invasion of the hepatic ducts, and medial segmentectomy was performed. As of the end of 1985, 58 cases of
hepatocellular carcinoma
complicated by extrahepatic
obstructive jaundice
have been reported in Japan. In only four was
obstructive jaundice
caused by extraluminal biliary compression. We review ten patients treated by liver resection.
...
PMID:Resection of hepatocellular carcinoma with obstructive jaundice caused by compression of the common hepatic duct. 284 68
Obstructive jaundice
due to growth within bile ducts of
hepatocellular carcinoma
is uncommon and usually a manifestation of advanced, lethal tumour. We report a case of fibrolamellar carcinoma of the liver presenting with
obstructive jaundice
, caused by tumorous permeation of the left hepatic duct with migration of tumour fragments into the common bile duct. Immunocytochemical and ultrastructural features are described. Two and a half years after complete surgical resection the patient is free of tumour. The importance of accurate diagnosis of such tumours is emphasized.
...
PMID:Fibrolamellar carcinoma as a cause of bile duct obstruction. 285 61
Transcatheter arterial embolization was performed on a patient with
hepatoma
complicated by
obstructive jaundice
after the patient's condition had been improved by percutaneous biliary drainage. As a result of the embolization, a reduction in size was observed in both the main tumor and the tumor that had invaded the common bile duct. Even after removing the biliary drainage tube, there was no recurrence of
obstructive jaundice
for 6 months.
...
PMID:Transcatheter arterial embolization in hepatoma complicated with obstructive jaundice. 302 32
A 67-year-old man presented with signs and symptoms of
obstructive jaundice
. At autopsy, a
hepatocellular carcinoma
was noted to have obstructed both hepatic ducts and the common hepatic duct. Literature is reviewed to elaborate on this unusual manifestation of
hepatocellular carcinoma
.
...
PMID:Hepatocellular carcinoma causing obstructive jaundice. 302 12
A radioimmunoassay for 3 beta-hydroxy-5-cholenoyl glycine in human urine has been developed. The antiserum was elicited with the antigen in which the steroid hapten is linked to a bovine serum albumin through the C-19 position. The [125I]-tyrosine derivative of the hapten was used as radioligand. The standard curves were linear ranging from 10 to 320 ng/mL. The cross-reactivities with other bile acids were not detectable and below 0.3% with cholesterol. Sample preparation includes extraction of 3 beta-hydroxy-5-cholenoyl glycine from urine and solvolysis of the sulfates--main form present in urine. Urinary excretion of 3 beta-hydroxy-5-cholenoyl glycine was 0.373 +/- 0.133 mumol/day in healthy adults. Urinary excretion of 3 beta-hydroxy-5-cholenoyl glycine increased in chronic liver dysfunction,
hepatoma
and
obstructive jaundice
in this order.
...
PMID:Radioimmunoassay of urinary 3 beta-hydroxy-5-cholenoyl glycine in hepatobiliary disease. 303 57
Two rare cases of autopsy and surgery presenting extrahepatic biliary obstruction due to intrabile-duct growth of
hepatocellular carcinoma
were reported. Clinically
obstructive jaundice
was predominant in comparison with the other symptoms in both cases. In one autopsy case,
hepatocellular carcinoma
developed in the right lobe of the cirrhotic liver (posthepatitic). It involved the secondary branch of the right hepatic duct and grew into the common hepatic duct. In the other case of surgical operation,
hepatocellular carcinoma
, which developed in the posterior portion of the right lobe of the cirrhotic liver (posthepatitic), destroyed the posterior wall of the bifurcation of the bilateral hepatic duct and obstructed the common hepatic duct due to the intraductal cancer growth. From the site of the bile duct invasion or permeation by the tumor, two cases were classified into the peripheral (the former case) and proximal (the latter case) types, respectively. Furthermore, as far as
obstructive jaundice
is clinically concerned, the possibility should be kept in mind that
hepatocellular carcinoma
may proliferate into the large bile ducts, apart from that of cholangiocarcinoma or cholelithiasis.
...
PMID:Hepatocellular carcinoma presenting extrahepatic obstructive jaundice due to bile duct invasion--clinicopathological study of two cases. 303 69
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>